Rivian hits production milestone for R2 EV ahead of customer deliveries

Rivian hits production milestone for R2 EV ahead of customer deliveries


Rivian founder and CEO RJ Scaringe on April 22, 2026 drives the first customer-ready electric R2 SUV off the assembly line at the company’s plant in Normal, Illinois.

Courtesy Rivian

Rivian Automotive on Wednesday said it has started production of its new R2 all-electric vehicle for customers at its plant in Normal, Illinois.

The start of production is a crucial milestone for the company ahead of customer deliveries, which are scheduled for later this spring. Investors will be watching for the company to ramp up production for the foreseeable future.

Rivian expects the R2 — an updated, less expensive EV that looks like its flagship R1 SUV — to attract more buyers and deliver on the company’s promises to cut costs and become profitable in the years ahead.

The first of the R2 midsize vehicles is a $58,000 performance model with a “Launch Package” that includes a 330-mile range, dual motors, special attributes and “lifetime” access to its Autonomy+ advanced driver-assistance system.

Why the R2 could be Rivian's key to profitability

Rivian has been touting a less expensive, entry-level version of the vehicle, starting at $45,000, but it said that model, which is expected to be less profitable, won’t be available until late 2027. Its current vehicles start at more than $70,000.

The R2 production announcement comes less than a week after a tornado damaged part of the company’s plant being used for R2 parts storage and logistics.

Rivian is scheduled to report its first-quarter results and update investors on R2 production on April 30.

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.



Source

CDC says there are no U.S. hantavirus cases currently, 41 people being monitored
Business

CDC says there are no U.S. hantavirus cases currently, 41 people being monitored

In this photo illustration Hantavirus samples are seen in Ankara, Turkiye on May 6, 2026. Arman Onal | Anadolu | Getty Images The U.S. Centers for Disease Control and Prevention said there are no hantavirus cases in the country as of Thursday, as it monitors 41 people for the virus. The agency said the risk […]

Read More
These three artworks could sell for 0 million each next week as May auctions begin
Business

These three artworks could sell for $100 million each next week as May auctions begin

A large-scale Jackson Pollock drip painting titled, “Number 7A, 1948.” Crystal Lau | CNBC A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Nearly $2 billion worth of art will come up […]

Read More
Biogen advances Alzheimer’s drug to late-stage trial despite disappointing data
Business

Biogen advances Alzheimer’s drug to late-stage trial despite disappointing data

A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen plans to advance an experimental drug for Alzheimer’s disease to late-stage testing despite disappointing mid-stage trial data, the company said Thursday. Biogen said its experimental drug that targets tau, a protein associated with the memory-robbing disease, failed to show better responses at higher doses. […]

Read More